Besides, a metanalysis by Barretta and colleagues, including 105,220 breast cancer patients from 60 studies, showed worse OS and worse breast cancer specific survival (BCSS) in BRCA1 mutation carriers while BRCA2 carriers had worse BCSS only in comparison to sporadic cases [27]. Here, BRCA2 is linked to breast cancer.